Aelis Farma: Ordinary General Meeting of June 28, 2022: Availability of Preparatory Documents and Participation and Voting Procedures

Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),

Related Keywords

United States ,France ,French ,Nicolas Merigeau ,Vincenzo Piazza ,Inserm Magendie Neurocentre ,Daelis Farma ,Albert Marquet ,Inserm Transfert Initiative ,Centre Broca Nouvelle Aquitaine ,Neurology Of The French Academy Sciences ,Regulatory News ,Ordinary General Meeting ,General Meeting ,Investors General ,Commercial Code ,Signaling Specific ,Pier Vincenzo Piazza ,Grand Prix ,French Academy ,Nouvelle Aquitaine Region ,Euronext Paris ,Marine De Fages ,Saelis ,Sarma ,Rdinary ,Eneral ,Meeting ,Pune ,022 ,Availability ,Preparatory ,Documents ,Participation ,Voting ,Procedures ,